XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows From Operating Activities:    
Net income $ 194,143 $ 242,180
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 114,396 114,379
Amortization of debt issuance costs and discounts 4,608 4,685
Deferred income tax provision 62,139 78,056
Equity-based compensation 12,809 13,975
Other, including loss on sale or disposal of assets, net 22,236 11,906
Changes in assets and liabilities:    
Accounts receivable (13,181) 1,160
Inventories 413 (30,739)
Prepaid expenses and other current assets 3,699 (4,401)
Accounts payable and accrued expenses (6,823) 11,176
Accrued salaries, wages and benefits 6,989 (2,996)
Deferred revenue (4,383) 17,815
Other accrued liabilities 9,095 7,779
Right of use assets and operating lease liabilities 329 469
Other assets and liabilities (8,012) 3,430
Net cash provided by operating activities 398,457 468,874
Cash Flows From Investing Activities:    
Capital expenditures (234,218) (150,729)
Net cash used in investing activities (234,218) (150,729)
Cash Flows From Financing Activities:    
Repayments of long-term debt (9,000) (9,000)
Proceeds from draws on revolving credit facility 20,000  
Repayments of revolving credit facility (20,000)  
Purchase of treasury stock (17,861) (617,756)
Payment of tax withholdings on equity-based compensation through shares withheld (6,561) (22,182)
Exercise of stock options 2,738 2,695
Debt issuance costs   (469)
Other financing activities (649) (427)
Net cash used in financing activities (31,333) (647,139)
Change in Cash and Cash Equivalents, including Restricted Cash 132,906 (328,994)
Cash and Cash Equivalents, including Restricted Cash—Beginning of period 82,320 444,486
Cash and Cash Equivalents, including Restricted Cash—End of period 215,226 115,492
Supplemental Disclosure of Noncash Investing and Financing Activities    
Capital expenditures in accounts payable 34,466 32,671
Right-of-use assets obtained in exchange for financing lease obligations $ 2,900 $ 5,298